Gene therapy trials held back by fragmented EU rules – pharmaphorum
pharmaphorum |
Gene therapy trials held back by fragmented EU rules
pharmaphorum Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials. The European Union has a strict legal regime around the use of any genetically … ARM, EBE, EFPIA and EuropaBio Jointly Publish Series of Proposals to Streamline Requirements and Accelerate … |
